Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in Locally Advanced Head & Neck Cancer
NCT01185171Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jan 2003
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in head and neck cancer (HNC), sponsored by University of Chicago. Started Jan 2003; status: completed.
02
Drugs
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT01185171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185171.